Protagonist Therapeutics

PTGXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$9.381 B

$144.98 +1.39%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

-$130.1M

Loss-making

Shares outstanding

64,708,285

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#35Arrowhead PharmaceuticalsARWR$9.72B
#36CytokineticsCYTK$9.39B
#37Protagonist TherapeuticsPTGX$9.38B
#38AbivaxABVX$8.91B
#39Tg TherapeuticsTGTX$8.75B

What if Protagonist Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.3T

$467,854.37

Per share 3,227× higher

Bitcoin $1.72T

$26,577.80

Per share 183× higher

Nvidia $5.48T

$84,685.57

Per share 584× higher

Or at a round number

$20.0B $50.0B $100.0B $200.0B

Where these numbers come from

Share counts and financials for Protagonist Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.